HOME >> MEDICINE >> NEWS
NPSF workshop builds community to improve pharmaceutical safety

Chicago, IL - On June 10-11, 1999, the National Patient Safety Foundation (NPSF) will convene a workshop in Washington, DC to design and build consensus around a collaborative action plan to promote pharmaceutical safety. Fifty opinion leaders will participate, representing five key stakeholder groups that can make a difference - the FDA & Government, Medicine & Health Care Practitioners, Pharmacists, Patients & Public Interest Groups, and the Pharmaceutical Industry.

"Each of these groups is working to assure pharmaceutical safety every day. But until all stakeholders in the pharmaceutical safety chain begin to align our strategies and work collaboratively, our efforts will not reach their full potential to maximize benefit and reduce risk and harm to patients," says Eleanor Vogt, RPh, PhD, Senior Fellow of the NPSF. "This workshop provides a neutral forum to leverage the discussion about underlying issues that keep the community from working together to advance safety."

Expected outcomes of this workshop include a collaborative action plan to be released this summer for a pharmaceutical safety initiative. The plan will incorporate the group consensus on the strengths and vulnerabilities of the system, the roles and responsibilities of the major players in the pharmaceutical chain, the existing tools and resources, and the gaps that need to be filled to responsibly address medication safety issues. It will serve as an action agenda for the work of the community as well as the NPSF.

This project is made possible by a public/private partnership reflected in a major grant from Pfizer Inc with additional support from Bristol-Myers Squibb Research Institute, CVS Drug Stores, DuPont Pharmaceuticals Company, the US Food and Drug Administration, the Warner-Lambert company and Janssen Pharmaceutica.

Founded in 1997 by the American Medical Association, CNA HealthPro, 3M, and other partners, the National Patient Safety Foundation is an independent, nonpro
'"/>

Contact: Susan Wagner
susan_wagner@ama-assn.org
312-464-5418
National Patient Safety Foundation
9-Jun-1999


Page: 1 2

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS workshop to explore pharmaceutical reference standards
8. AAPS presents workshop on macromolecules
9. Exercise therapy builds strength, mobility in MS patients
10. Success of experimental herpes vaccine builds momentum for human clinical trials
11. Privacy rule builds biomedical research bottleneck

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NPSF workshop builds community improve pharmaceutical safety

(Date:4/1/2015)... Peoria, Ill. (PRWEB) April 01, 2015 ... the OSF Healthcare System , was welcomed into ... Dedication Ceremony officiated by Msgr. Paul E. Showalter, vicar ... , The Blessing and Dedication culminated a nearly year-long ... the eleventh OSF HealthCare hospital. Speakers for the morning ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 ... senior care, today announces the launch of the ... innovative senior care stakeholders and technology companies. The announcement ... Center (NIC) Capital and Business Strategies Forum in ... members, the new Alliance program is now open for ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , Dallas ... Department of Plastic Surgery at UT Southwestern Medical Center, ... blindness resulting from the use of facial aesthetic ... study, along with ideas for treatment and prevention in ... to see increasing reports of blindness as a result ...
(Date:4/1/2015)... GA (PRWEB) April 01, 2015 ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital ... has partnered with AgileMD to provide the content ... , in a mobile application format available on ... , “Our collaboration with AgileMD to develop mobile ...
(Date:4/1/2015)... 2015 Skin cancer is one of the ... caught early. Forefront Dermatology and Dermatology Associates of Wisconsin want ... before it spreads so they are hosting a free skin ... 8:30am - 12:30pm. , “If we can see the ... concern, that could become cancerous,” said Dr. Ken Katz, who ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2
(Date:4/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kz78wm/medical_device ) ... Device Studies: Clinical Evidence" conference to their ... specifically for those who are involved in gathering ... diagnostic products. Clinical data is required for all ... appropriate clinical evidence has grown substantially in the ...
(Date:4/1/2015)... Md. , April 1, 2015  RegeneRx ... today announced that a new medical paper has ... beta 4 (TB4) in patients with severe dry ... the study and the physicians stated that statistically ... severe dry eye were seen at various time ...
(Date:4/1/2015)... LAVAL, Quebec , April 1, ... Inc. (NYSE: VRX and ... completed the previously announced acquisition of ... a specialty pharmaceutical company that offers ...  (rifaximin) 550 mg, RUCONEST ®  (C1 esterase inhibitor ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
Cached News: